Prokidney (PROK) Enterprise Value (2021 - 2026)

Prokidney (PROK) has 6 years of Enterprise Value data on file, last reported at -$101.9 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 4.18% year-over-year to -$101.9 million in Q1 2026; TTM through Mar 2026 was -$101.9 million, a 4.18% decrease from a year earlier, with the FY2025 full-year figure at -$108.5 million, down 9.5% from the prior year.
• Enterprise Value for Q1 2026 stood at -$101.9 million, up from -$108.5 million in the prior quarter.
• Over the last five years, Enterprise Value for PROK reached as high as -$60.6 million in Q4 2023 and fell as low as -$506.3 million in Q3 2022.
• Historically, Enterprise Value has averaged -$183.9 million across 5 years, with a median of -$108.1 million in 2024.
• Across the five-year window, Enterprise Value slumped 2284.73% in 2022 and soared 87.63% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$490.3 million in 2022, then surged by 87.63% to -$60.6 million in 2023, then tumbled by 63.43% to -$99.1 million in 2024, then retreated by 9.5% to -$108.5 million in 2025, then grew by 6.12% to -$101.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$101.9 million in Q1 2026, -$108.5 million in Q4 2025, and -$95.3 million in Q3 2025.